Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn

Index by author

October 01, 2014; Volume 351,Issue 1
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

A

  1. Abdel-Rahman, Abdel A.

    1. You have access
      Neuronal Nitric Oxide Synthase–Dependent Elevation in Adiponectin in the Rostral Ventrolateral Medulla Underlies G Protein–Coupled Receptor 18–Mediated Hypotension in Conscious Rats
      Anusha Penumarti and Abdel A. Abdel-Rahman
      Journal of Pharmacology and Experimental Therapeutics October 2014, 351 (1) 44-53; DOI: https://doi.org/10.1124/jpet.114.216036
  2. Al-Zaubai, Nuha

    1. You have access
      Resolvin D2 Supports MCF-7 Cell Proliferation via Activation of Estrogen Receptor
      Nuha Al-Zaubai, Cameron N. Johnstone, May May Leong, John Li, Mark Rizzacasa and Alastair G. Stewart
      Journal of Pharmacology and Experimental Therapeutics October 2014, 351 (1) 172-180; DOI: https://doi.org/10.1124/jpet.114.214403
  3. Amella, Carol A.

    1. You have access
      Pegylation Improves the Pharmacokinetics and Bioavailability of Small-Molecule Drugs Hydrolyzable by Esterases: A Study of Phospho-Ibuprofen
      George Mattheolabakis, Chi C. Wong, Yu Sun, Carol A. Amella, Robert Richards, Panayiotis P. Constantinides and Basil Rigas
      Journal of Pharmacology and Experimental Therapeutics October 2014, 351 (1) 61-66; DOI: https://doi.org/10.1124/jpet.114.217208
  4. Antony, Veena

    1. You have access
      Therapeutic Targeting of Src Kinase in Myofibroblast Differentiation and Pulmonary Fibrosis
      Meng Hu, Pulin Che, Xiaosi Han, Guo-Qiang Cai, Gang Liu, Veena Antony, Tracy Luckhardt, Gene P. Siegal, Yong Zhou, Rui-ming Liu, Leena P. Desai, Philip J. O’Reilly, Victor J. Thannickal and Qiang Ding
      Journal of Pharmacology and Experimental Therapeutics October 2014, 351 (1) 87-95; DOI: https://doi.org/10.1124/jpet.114.216044
  5. Ayroldi, Emira

    1. You have access
      Pharmacological Modulation of Caspase-8 in Thymus-Related Medical Conditions
      Nicola Pozzesi, Alessandra Fierabracci, Trinh Thy Thuy, Maria Paola Martelli, Anna Marina Liberati, Emira Ayroldi, Carlo Riccardi and Domenico V. Delfino
      Journal of Pharmacology and Experimental Therapeutics October 2014, 351 (1) 18-24; DOI: https://doi.org/10.1124/jpet.114.216572

B

  1. Banks, William A.

    1. You have access
      Intranasal Administration as a Route for Drug Delivery to the Brain: Evidence for a Unique Pathway for Albumin
      Joseph A. Falcone, Therese S. Salameh, Xiang Yi, Benjamin J. Cordy, William G. Mortell, Alexander V. Kabanov and William A. Banks
      Journal of Pharmacology and Experimental Therapeutics October 2014, 351 (1) 54-60; DOI: https://doi.org/10.1124/jpet.114.216705
  2. Beaudry, Rhys

    1. You have access
      Modulation of Resistance Artery Tone by the Trace Amine β-Phenylethylamine: Dual Indirect Sympathomimetic and α1-Adrenoceptor Blocking Actions
      Deepak Narang, Paul M. Kerr, Stephanie E. Lunn, Rhys Beaudry, Julie Sigurdson, Margaret D. Lalies, Alan L. Hudson, Peter E. Light, Andrew Holt and Frances Plane
      Journal of Pharmacology and Experimental Therapeutics October 2014, 351 (1) 164-171; DOI: https://doi.org/10.1124/jpet.114.216523
  3. Bee, Lucy A.

    1. You have access
      Synergistic Effect of 5-Hydroxytryptamine 3 and Neurokinin 1 Receptor Antagonism in Rodent Models of Somatic and Visceral Pain
      Beverley Greenwood-Van Meerveld, Ehsan Mohammadi, Karl Tyler, Claudio Pietra, Lucy A. Bee and Anthony Dickenson
      Journal of Pharmacology and Experimental Therapeutics October 2014, 351 (1) 146-152; DOI: https://doi.org/10.1124/jpet.114.216028
  4. Bi, Yi-an

    1. You have access
      Quantitative Prediction of Transporter- and Enzyme-Mediated Clinical Drug-Drug Interactions of Organic Anion-Transporting Polypeptide 1B1 Substrates Using a Mechanistic Net-Effect Model
      Manthena V. Varma, Yi-an Bi, Emi Kimoto and Jian Lin
      Journal of Pharmacology and Experimental Therapeutics October 2014, 351 (1) 214-223; DOI: https://doi.org/10.1124/jpet.114.215970
  5. Brancaleone, Vincenzo

    1. You have access
      Annexin A1 Mediates Hydrogen Sulfide Properties in the Control of Inflammation
      Vincenzo Brancaleone, Emma Mitidieri, Roderick J. Flower, Giuseppe Cirino and Mauro Perretti
      Journal of Pharmacology and Experimental Therapeutics October 2014, 351 (1) 96-104; DOI: https://doi.org/10.1124/jpet.114.217034

C

  1. Cai, Guo-Qiang

    1. You have access
      Therapeutic Targeting of Src Kinase in Myofibroblast Differentiation and Pulmonary Fibrosis
      Meng Hu, Pulin Che, Xiaosi Han, Guo-Qiang Cai, Gang Liu, Veena Antony, Tracy Luckhardt, Gene P. Siegal, Yong Zhou, Rui-ming Liu, Leena P. Desai, Philip J. O’Reilly, Victor J. Thannickal and Qiang Ding
      Journal of Pharmacology and Experimental Therapeutics October 2014, 351 (1) 87-95; DOI: https://doi.org/10.1124/jpet.114.216044
  2. Camargo, Simone M. R.

    1. You have access
      The Molecular Mechanism of Intestinal Levodopa Absorption and Its Possible Implications for the Treatment of Parkinson’s Disease
      Simone M. R. Camargo, Raphael N. Vuille-dit-Bille, Luca Mariotta, Tamara Ramadan, Katja Huggel, Dustin Singer, Oliver Götze and François Verrey
      Journal of Pharmacology and Experimental Therapeutics October 2014, 351 (1) 114-123; DOI: https://doi.org/10.1124/jpet.114.216317
  3. Carcolé, Mireia

    1. You have access
      Treatment with a Heme Oxygenase 1 Inducer Enhances the Antinociceptive Effects of µ-Opioid, δ-Opioid, and Cannabinoid 2 Receptors during Inflammatory Pain
      Mireia Carcolé, Sílvia Castany, Sergi Leánez and Olga Pol
      Journal of Pharmacology and Experimental Therapeutics October 2014, 351 (1) 224-232; DOI: https://doi.org/10.1124/jpet.114.215681
  4. Carmack, Terry L.

    1. You have access
      Relationship between Cerebral Sigma-1 Receptor Occupancy and Attenuation of Cocaine’s Motor Stimulatory Effects in Mice by PD144418
      John R. Lever, Dennis K. Miller, Emily A. Fergason-Cantrell, Caroline L. Green, Lisa D. Watkinson, Terry L. Carmack and Susan Z. Lever
      Journal of Pharmacology and Experimental Therapeutics October 2014, 351 (1) 153-163; DOI: https://doi.org/10.1124/jpet.114.216671
  5. Castany, Sílvia

    1. You have access
      Treatment with a Heme Oxygenase 1 Inducer Enhances the Antinociceptive Effects of µ-Opioid, δ-Opioid, and Cannabinoid 2 Receptors during Inflammatory Pain
      Mireia Carcolé, Sílvia Castany, Sergi Leánez and Olga Pol
      Journal of Pharmacology and Experimental Therapeutics October 2014, 351 (1) 224-232; DOI: https://doi.org/10.1124/jpet.114.215681
  6. Chappell, A. S.

    1. You have access
      Perampanel, an Antagonist of α-Amino-3-Hydroxy-5-Methyl-4-Isoxazolepropionic Acid Receptors, for the Treatment of Epilepsy: Studies in Human Epileptic Brain and Nonepileptic Brain and in Rodent Models
      R. Zwart, E. Sher, X. Ping, X. Jin, J. R. Sims, A. S. Chappell, S. D. Gleason, P. J. Hahn, K. Gardinier, D. L. Gernert, J. Hobbs, J. L. Smith, S. N. Valli and J. M. Witkin
      Journal of Pharmacology and Experimental Therapeutics October 2014, 351 (1) 124-133; DOI: https://doi.org/10.1124/jpet.114.212779
  7. Che, Pulin

    1. You have access
      Therapeutic Targeting of Src Kinase in Myofibroblast Differentiation and Pulmonary Fibrosis
      Meng Hu, Pulin Che, Xiaosi Han, Guo-Qiang Cai, Gang Liu, Veena Antony, Tracy Luckhardt, Gene P. Siegal, Yong Zhou, Rui-ming Liu, Leena P. Desai, Philip J. O’Reilly, Victor J. Thannickal and Qiang Ding
      Journal of Pharmacology and Experimental Therapeutics October 2014, 351 (1) 87-95; DOI: https://doi.org/10.1124/jpet.114.216044
  8. Chen, Yan

    1. You have access
      Pharmacologic Characterization of GSK-961081 (TD-5959), a First-in-Class Inhaled Bifunctional Bronchodilator Possessing Muscarinic Receptor Antagonist and β2-Adrenoceptor Agonist Properties
      Sharath S. Hegde, Adam D. Hughes, Yan Chen, Tod Steinfeld, Jeffrey R. Jasper, Tae-Weon Lee, Alexander McNamara, William J. Martin, M. Teresa Pulido-Rios and Mathai Mammen
      Journal of Pharmacology and Experimental Therapeutics October 2014, 351 (1) 190-199; DOI: https://doi.org/10.1124/jpet.114.216861
  9. Cheng, Xingguo

    1. You have access
      Decreased Bile-Acid Synthesis in Livers of Hepatocyte-Conditional NADPH–Cytochrome P450 Reductase–Null Mice Results in Increased Bile Acids in Serum
      Xingguo Cheng, Youcai Zhang and Curtis D. Klaassen
      Journal of Pharmacology and Experimental Therapeutics October 2014, 351 (1) 105-113; DOI: https://doi.org/10.1124/jpet.114.216796
  10. Cirino, Giuseppe

    1. You have access
      Annexin A1 Mediates Hydrogen Sulfide Properties in the Control of Inflammation
      Vincenzo Brancaleone, Emma Mitidieri, Roderick J. Flower, Giuseppe Cirino and Mauro Perretti
      Journal of Pharmacology and Experimental Therapeutics October 2014, 351 (1) 96-104; DOI: https://doi.org/10.1124/jpet.114.217034
  11. Cleator, John H.

    1. You have access
      Racial Differences in Resistance to P2Y12 Receptor Antagonists in Type 2 Diabetic Subjects
      John H. Cleator, Matthew T. Duvernay, Michael Holinstat, Nancy E. Colowick, Willie J. Hudson, Yanna Song, Frank E. Harrell and Heidi E. Hamm
      Journal of Pharmacology and Experimental Therapeutics October 2014, 351 (1) 33-43; DOI: https://doi.org/10.1124/jpet.114.215616
  12. Colowick, Nancy E.

    1. You have access
      Racial Differences in Resistance to P2Y12 Receptor Antagonists in Type 2 Diabetic Subjects
      John H. Cleator, Matthew T. Duvernay, Michael Holinstat, Nancy E. Colowick, Willie J. Hudson, Yanna Song, Frank E. Harrell and Heidi E. Hamm
      Journal of Pharmacology and Experimental Therapeutics October 2014, 351 (1) 33-43; DOI: https://doi.org/10.1124/jpet.114.215616
  13. Constantinides, Panayiotis P.

    1. You have access
      Pegylation Improves the Pharmacokinetics and Bioavailability of Small-Molecule Drugs Hydrolyzable by Esterases: A Study of Phospho-Ibuprofen
      George Mattheolabakis, Chi C. Wong, Yu Sun, Carol A. Amella, Robert Richards, Panayiotis P. Constantinides and Basil Rigas
      Journal of Pharmacology and Experimental Therapeutics October 2014, 351 (1) 61-66; DOI: https://doi.org/10.1124/jpet.114.217208
  14. Cordy, Benjamin J.

    1. You have access
      Intranasal Administration as a Route for Drug Delivery to the Brain: Evidence for a Unique Pathway for Albumin
      Joseph A. Falcone, Therese S. Salameh, Xiang Yi, Benjamin J. Cordy, William G. Mortell, Alexander V. Kabanov and William A. Banks
      Journal of Pharmacology and Experimental Therapeutics October 2014, 351 (1) 54-60; DOI: https://doi.org/10.1124/jpet.114.216705

D

  1. Decker, Michael W.

    1. You have access
      The α7 Nicotinic Receptor Agonist ABT-107 Decreases l-Dopa–Induced Dyskinesias in Parkinsonian Monkeys
      Danhui Zhang, Matthew McGregor, Michael W. Decker and Maryka Quik
      Journal of Pharmacology and Experimental Therapeutics October 2014, 351 (1) 25-32; DOI: https://doi.org/10.1124/jpet.114.216283
  2. Delfino, Domenico V.

    1. You have access
      Pharmacological Modulation of Caspase-8 in Thymus-Related Medical Conditions
      Nicola Pozzesi, Alessandra Fierabracci, Trinh Thy Thuy, Maria Paola Martelli, Anna Marina Liberati, Emira Ayroldi, Carlo Riccardi and Domenico V. Delfino
      Journal of Pharmacology and Experimental Therapeutics October 2014, 351 (1) 18-24; DOI: https://doi.org/10.1124/jpet.114.216572
  3. Desai, Leena P.

    1. You have access
      Therapeutic Targeting of Src Kinase in Myofibroblast Differentiation and Pulmonary Fibrosis
      Meng Hu, Pulin Che, Xiaosi Han, Guo-Qiang Cai, Gang Liu, Veena Antony, Tracy Luckhardt, Gene P. Siegal, Yong Zhou, Rui-ming Liu, Leena P. Desai, Philip J. O’Reilly, Victor J. Thannickal and Qiang Ding
      Journal of Pharmacology and Experimental Therapeutics October 2014, 351 (1) 87-95; DOI: https://doi.org/10.1124/jpet.114.216044
  4. Dickenson, Anthony

    1. You have access
      Synergistic Effect of 5-Hydroxytryptamine 3 and Neurokinin 1 Receptor Antagonism in Rodent Models of Somatic and Visceral Pain
      Beverley Greenwood-Van Meerveld, Ehsan Mohammadi, Karl Tyler, Claudio Pietra, Lucy A. Bee and Anthony Dickenson
      Journal of Pharmacology and Experimental Therapeutics October 2014, 351 (1) 146-152; DOI: https://doi.org/10.1124/jpet.114.216028
  5. Ding, Qiang

    1. You have access
      Therapeutic Targeting of Src Kinase in Myofibroblast Differentiation and Pulmonary Fibrosis
      Meng Hu, Pulin Che, Xiaosi Han, Guo-Qiang Cai, Gang Liu, Veena Antony, Tracy Luckhardt, Gene P. Siegal, Yong Zhou, Rui-ming Liu, Leena P. Desai, Philip J. O’Reilly, Victor J. Thannickal and Qiang Ding
      Journal of Pharmacology and Experimental Therapeutics October 2014, 351 (1) 87-95; DOI: https://doi.org/10.1124/jpet.114.216044
  6. Duvernay, Matthew T.

    1. You have access
      Racial Differences in Resistance to P2Y12 Receptor Antagonists in Type 2 Diabetic Subjects
      John H. Cleator, Matthew T. Duvernay, Michael Holinstat, Nancy E. Colowick, Willie J. Hudson, Yanna Song, Frank E. Harrell and Heidi E. Hamm
      Journal of Pharmacology and Experimental Therapeutics October 2014, 351 (1) 33-43; DOI: https://doi.org/10.1124/jpet.114.215616

F

  1. Falcone, Joseph A.

    1. You have access
      Intranasal Administration as a Route for Drug Delivery to the Brain: Evidence for a Unique Pathway for Albumin
      Joseph A. Falcone, Therese S. Salameh, Xiang Yi, Benjamin J. Cordy, William G. Mortell, Alexander V. Kabanov and William A. Banks
      Journal of Pharmacology and Experimental Therapeutics October 2014, 351 (1) 54-60; DOI: https://doi.org/10.1124/jpet.114.216705
  2. Fergason-Cantrell, Emily A.

    1. You have access
      Relationship between Cerebral Sigma-1 Receptor Occupancy and Attenuation of Cocaine’s Motor Stimulatory Effects in Mice by PD144418
      John R. Lever, Dennis K. Miller, Emily A. Fergason-Cantrell, Caroline L. Green, Lisa D. Watkinson, Terry L. Carmack and Susan Z. Lever
      Journal of Pharmacology and Experimental Therapeutics October 2014, 351 (1) 153-163; DOI: https://doi.org/10.1124/jpet.114.216671
  3. Fierabracci, Alessandra

    1. You have access
      Pharmacological Modulation of Caspase-8 in Thymus-Related Medical Conditions
      Nicola Pozzesi, Alessandra Fierabracci, Trinh Thy Thuy, Maria Paola Martelli, Anna Marina Liberati, Emira Ayroldi, Carlo Riccardi and Domenico V. Delfino
      Journal of Pharmacology and Experimental Therapeutics October 2014, 351 (1) 18-24; DOI: https://doi.org/10.1124/jpet.114.216572
  4. Flower, Roderick J.

    1. You have access
      Annexin A1 Mediates Hydrogen Sulfide Properties in the Control of Inflammation
      Vincenzo Brancaleone, Emma Mitidieri, Roderick J. Flower, Giuseppe Cirino and Mauro Perretti
      Journal of Pharmacology and Experimental Therapeutics October 2014, 351 (1) 96-104; DOI: https://doi.org/10.1124/jpet.114.217034
  5. Fukasawa, Masayoshi

    1. You have access
      Development of an Anti–Claudin-3 and -4 Bispecific Monoclonal Antibody for Cancer Diagnosis and Therapy
      Xiangru Li, Manami Iida, Minoru Tada, Akihiro Watari, Yumi Kawahigashi, Yuka Kimura, Taku Yamashita, Akiko Ishii-Watabe, Tadayuki Uno, Masayoshi Fukasawa, Hiroki Kuniyasu, Kiyohito Yagi and Masuo Kondoh
      Journal of Pharmacology and Experimental Therapeutics October 2014, 351 (1) 206-213; DOI: https://doi.org/10.1124/jpet.114.216911

G

  1. Gardinier, K.

    1. You have access
      Perampanel, an Antagonist of α-Amino-3-Hydroxy-5-Methyl-4-Isoxazolepropionic Acid Receptors, for the Treatment of Epilepsy: Studies in Human Epileptic Brain and Nonepileptic Brain and in Rodent Models
      R. Zwart, E. Sher, X. Ping, X. Jin, J. R. Sims, A. S. Chappell, S. D. Gleason, P. J. Hahn, K. Gardinier, D. L. Gernert, J. Hobbs, J. L. Smith, S. N. Valli and J. M. Witkin
      Journal of Pharmacology and Experimental Therapeutics October 2014, 351 (1) 124-133; DOI: https://doi.org/10.1124/jpet.114.212779
  2. Gernert, D. L.

    1. You have access
      Perampanel, an Antagonist of α-Amino-3-Hydroxy-5-Methyl-4-Isoxazolepropionic Acid Receptors, for the Treatment of Epilepsy: Studies in Human Epileptic Brain and Nonepileptic Brain and in Rodent Models
      R. Zwart, E. Sher, X. Ping, X. Jin, J. R. Sims, A. S. Chappell, S. D. Gleason, P. J. Hahn, K. Gardinier, D. L. Gernert, J. Hobbs, J. L. Smith, S. N. Valli and J. M. Witkin
      Journal of Pharmacology and Experimental Therapeutics October 2014, 351 (1) 124-133; DOI: https://doi.org/10.1124/jpet.114.212779
  3. Gleason, S. D.

    1. You have access
      Perampanel, an Antagonist of α-Amino-3-Hydroxy-5-Methyl-4-Isoxazolepropionic Acid Receptors, for the Treatment of Epilepsy: Studies in Human Epileptic Brain and Nonepileptic Brain and in Rodent Models
      R. Zwart, E. Sher, X. Ping, X. Jin, J. R. Sims, A. S. Chappell, S. D. Gleason, P. J. Hahn, K. Gardinier, D. L. Gernert, J. Hobbs, J. L. Smith, S. N. Valli and J. M. Witkin
      Journal of Pharmacology and Experimental Therapeutics October 2014, 351 (1) 124-133; DOI: https://doi.org/10.1124/jpet.114.212779
  4. Götze, Oliver

    1. You have access
      The Molecular Mechanism of Intestinal Levodopa Absorption and Its Possible Implications for the Treatment of Parkinson’s Disease
      Simone M. R. Camargo, Raphael N. Vuille-dit-Bille, Luca Mariotta, Tamara Ramadan, Katja Huggel, Dustin Singer, Oliver Götze and François Verrey
      Journal of Pharmacology and Experimental Therapeutics October 2014, 351 (1) 114-123; DOI: https://doi.org/10.1124/jpet.114.216317
  5. Green, Caroline L.

    1. You have access
      Relationship between Cerebral Sigma-1 Receptor Occupancy and Attenuation of Cocaine’s Motor Stimulatory Effects in Mice by PD144418
      John R. Lever, Dennis K. Miller, Emily A. Fergason-Cantrell, Caroline L. Green, Lisa D. Watkinson, Terry L. Carmack and Susan Z. Lever
      Journal of Pharmacology and Experimental Therapeutics October 2014, 351 (1) 153-163; DOI: https://doi.org/10.1124/jpet.114.216671
  6. Greenwood-Van Meerveld, Beverley

    1. You have access
      Synergistic Effect of 5-Hydroxytryptamine 3 and Neurokinin 1 Receptor Antagonism in Rodent Models of Somatic and Visceral Pain
      Beverley Greenwood-Van Meerveld, Ehsan Mohammadi, Karl Tyler, Claudio Pietra, Lucy A. Bee and Anthony Dickenson
      Journal of Pharmacology and Experimental Therapeutics October 2014, 351 (1) 146-152; DOI: https://doi.org/10.1124/jpet.114.216028

H

  1. Hahn, P. J.

    1. You have access
      Perampanel, an Antagonist of α-Amino-3-Hydroxy-5-Methyl-4-Isoxazolepropionic Acid Receptors, for the Treatment of Epilepsy: Studies in Human Epileptic Brain and Nonepileptic Brain and in Rodent Models
      R. Zwart, E. Sher, X. Ping, X. Jin, J. R. Sims, A. S. Chappell, S. D. Gleason, P. J. Hahn, K. Gardinier, D. L. Gernert, J. Hobbs, J. L. Smith, S. N. Valli and J. M. Witkin
      Journal of Pharmacology and Experimental Therapeutics October 2014, 351 (1) 124-133; DOI: https://doi.org/10.1124/jpet.114.212779
  2. Hamm, Heidi E.

    1. You have access
      Racial Differences in Resistance to P2Y12 Receptor Antagonists in Type 2 Diabetic Subjects
      John H. Cleator, Matthew T. Duvernay, Michael Holinstat, Nancy E. Colowick, Willie J. Hudson, Yanna Song, Frank E. Harrell and Heidi E. Hamm
      Journal of Pharmacology and Experimental Therapeutics October 2014, 351 (1) 33-43; DOI: https://doi.org/10.1124/jpet.114.215616
  3. Han, Xiaosi

    1. You have access
      Therapeutic Targeting of Src Kinase in Myofibroblast Differentiation and Pulmonary Fibrosis
      Meng Hu, Pulin Che, Xiaosi Han, Guo-Qiang Cai, Gang Liu, Veena Antony, Tracy Luckhardt, Gene P. Siegal, Yong Zhou, Rui-ming Liu, Leena P. Desai, Philip J. O’Reilly, Victor J. Thannickal and Qiang Ding
      Journal of Pharmacology and Experimental Therapeutics October 2014, 351 (1) 87-95; DOI: https://doi.org/10.1124/jpet.114.216044
  4. Harrell, Frank E.

    1. You have access
      Racial Differences in Resistance to P2Y12 Receptor Antagonists in Type 2 Diabetic Subjects
      John H. Cleator, Matthew T. Duvernay, Michael Holinstat, Nancy E. Colowick, Willie J. Hudson, Yanna Song, Frank E. Harrell and Heidi E. Hamm
      Journal of Pharmacology and Experimental Therapeutics October 2014, 351 (1) 33-43; DOI: https://doi.org/10.1124/jpet.114.215616
  5. Hashimoto, Terumasa

    1. You have access
      Two Types of Overcontraction Are Involved in Intrarenal Artery Dysfunction in Type II Diabetic Mouse
      Koji Nobe, Yasuhiro Takenouchi, Keizo Kasono, Terumasa Hashimoto and Kazuo Honda
      Journal of Pharmacology and Experimental Therapeutics October 2014, 351 (1) 77-86; DOI: https://doi.org/10.1124/jpet.114.216747
  6. Hegde, Sharath S.

    1. You have access
      Pharmacologic Characterization of GSK-961081 (TD-5959), a First-in-Class Inhaled Bifunctional Bronchodilator Possessing Muscarinic Receptor Antagonist and β2-Adrenoceptor Agonist Properties
      Sharath S. Hegde, Adam D. Hughes, Yan Chen, Tod Steinfeld, Jeffrey R. Jasper, Tae-Weon Lee, Alexander McNamara, William J. Martin, M. Teresa Pulido-Rios and Mathai Mammen
      Journal of Pharmacology and Experimental Therapeutics October 2014, 351 (1) 190-199; DOI: https://doi.org/10.1124/jpet.114.216861
  7. Hobbs, J.

    1. You have access
      Perampanel, an Antagonist of α-Amino-3-Hydroxy-5-Methyl-4-Isoxazolepropionic Acid Receptors, for the Treatment of Epilepsy: Studies in Human Epileptic Brain and Nonepileptic Brain and in Rodent Models
      R. Zwart, E. Sher, X. Ping, X. Jin, J. R. Sims, A. S. Chappell, S. D. Gleason, P. J. Hahn, K. Gardinier, D. L. Gernert, J. Hobbs, J. L. Smith, S. N. Valli and J. M. Witkin
      Journal of Pharmacology and Experimental Therapeutics October 2014, 351 (1) 124-133; DOI: https://doi.org/10.1124/jpet.114.212779
  8. Holinstat, Michael

    1. You have access
      Racial Differences in Resistance to P2Y12 Receptor Antagonists in Type 2 Diabetic Subjects
      John H. Cleator, Matthew T. Duvernay, Michael Holinstat, Nancy E. Colowick, Willie J. Hudson, Yanna Song, Frank E. Harrell and Heidi E. Hamm
      Journal of Pharmacology and Experimental Therapeutics October 2014, 351 (1) 33-43; DOI: https://doi.org/10.1124/jpet.114.215616
  9. Holt, Andrew

    1. You have access
      Modulation of Resistance Artery Tone by the Trace Amine β-Phenylethylamine: Dual Indirect Sympathomimetic and α1-Adrenoceptor Blocking Actions
      Deepak Narang, Paul M. Kerr, Stephanie E. Lunn, Rhys Beaudry, Julie Sigurdson, Margaret D. Lalies, Alan L. Hudson, Peter E. Light, Andrew Holt and Frances Plane
      Journal of Pharmacology and Experimental Therapeutics October 2014, 351 (1) 164-171; DOI: https://doi.org/10.1124/jpet.114.216523
  10. Honda, Kazuo

    1. You have access
      Two Types of Overcontraction Are Involved in Intrarenal Artery Dysfunction in Type II Diabetic Mouse
      Koji Nobe, Yasuhiro Takenouchi, Keizo Kasono, Terumasa Hashimoto and Kazuo Honda
      Journal of Pharmacology and Experimental Therapeutics October 2014, 351 (1) 77-86; DOI: https://doi.org/10.1124/jpet.114.216747
  11. Hu, Meng

    1. You have access
      Therapeutic Targeting of Src Kinase in Myofibroblast Differentiation and Pulmonary Fibrosis
      Meng Hu, Pulin Che, Xiaosi Han, Guo-Qiang Cai, Gang Liu, Veena Antony, Tracy Luckhardt, Gene P. Siegal, Yong Zhou, Rui-ming Liu, Leena P. Desai, Philip J. O’Reilly, Victor J. Thannickal and Qiang Ding
      Journal of Pharmacology and Experimental Therapeutics October 2014, 351 (1) 87-95; DOI: https://doi.org/10.1124/jpet.114.216044
  12. Huang, Shu Kuei

    1. You have access
      Cyclooxygenase 2 Inhibitor Celecoxib Inhibits Glutamate Release by Attenuating the PGE2/EP2 Pathway in Rat Cerebral Cortex Endings
      Tzu-Yu Lin, Cheng-Wei Lu, Chia-Chuan Wang, Shu Kuei Huang and Su-Jane Wang
      Journal of Pharmacology and Experimental Therapeutics October 2014, 351 (1) 134-145; DOI: https://doi.org/10.1124/jpet.114.217372
  13. Hudson, Alan L.

    1. You have access
      Modulation of Resistance Artery Tone by the Trace Amine β-Phenylethylamine: Dual Indirect Sympathomimetic and α1-Adrenoceptor Blocking Actions
      Deepak Narang, Paul M. Kerr, Stephanie E. Lunn, Rhys Beaudry, Julie Sigurdson, Margaret D. Lalies, Alan L. Hudson, Peter E. Light, Andrew Holt and Frances Plane
      Journal of Pharmacology and Experimental Therapeutics October 2014, 351 (1) 164-171; DOI: https://doi.org/10.1124/jpet.114.216523
  14. Hudson, Willie J.

    1. You have access
      Racial Differences in Resistance to P2Y12 Receptor Antagonists in Type 2 Diabetic Subjects
      John H. Cleator, Matthew T. Duvernay, Michael Holinstat, Nancy E. Colowick, Willie J. Hudson, Yanna Song, Frank E. Harrell and Heidi E. Hamm
      Journal of Pharmacology and Experimental Therapeutics October 2014, 351 (1) 33-43; DOI: https://doi.org/10.1124/jpet.114.215616
  15. Huggel, Katja

    1. You have access
      The Molecular Mechanism of Intestinal Levodopa Absorption and Its Possible Implications for the Treatment of Parkinson’s Disease
      Simone M. R. Camargo, Raphael N. Vuille-dit-Bille, Luca Mariotta, Tamara Ramadan, Katja Huggel, Dustin Singer, Oliver Götze and François Verrey
      Journal of Pharmacology and Experimental Therapeutics October 2014, 351 (1) 114-123; DOI: https://doi.org/10.1124/jpet.114.216317
  16. Hughes, Adam D.

    1. You have access
      Pharmacologic Characterization of GSK-961081 (TD-5959), a First-in-Class Inhaled Bifunctional Bronchodilator Possessing Muscarinic Receptor Antagonist and β2-Adrenoceptor Agonist Properties
      Sharath S. Hegde, Adam D. Hughes, Yan Chen, Tod Steinfeld, Jeffrey R. Jasper, Tae-Weon Lee, Alexander McNamara, William J. Martin, M. Teresa Pulido-Rios and Mathai Mammen
      Journal of Pharmacology and Experimental Therapeutics October 2014, 351 (1) 190-199; DOI: https://doi.org/10.1124/jpet.114.216861

I

  1. Iida, Manami

    1. You have access
      Development of an Anti–Claudin-3 and -4 Bispecific Monoclonal Antibody for Cancer Diagnosis and Therapy
      Xiangru Li, Manami Iida, Minoru Tada, Akihiro Watari, Yumi Kawahigashi, Yuka Kimura, Taku Yamashita, Akiko Ishii-Watabe, Tadayuki Uno, Masayoshi Fukasawa, Hiroki Kuniyasu, Kiyohito Yagi and Masuo Kondoh
      Journal of Pharmacology and Experimental Therapeutics October 2014, 351 (1) 206-213; DOI: https://doi.org/10.1124/jpet.114.216911
  2. Ishii-Watabe, Akiko

    1. You have access
      Development of an Anti–Claudin-3 and -4 Bispecific Monoclonal Antibody for Cancer Diagnosis and Therapy
      Xiangru Li, Manami Iida, Minoru Tada, Akihiro Watari, Yumi Kawahigashi, Yuka Kimura, Taku Yamashita, Akiko Ishii-Watabe, Tadayuki Uno, Masayoshi Fukasawa, Hiroki Kuniyasu, Kiyohito Yagi and Masuo Kondoh
      Journal of Pharmacology and Experimental Therapeutics October 2014, 351 (1) 206-213; DOI: https://doi.org/10.1124/jpet.114.216911
  3. Iwamura, Tomokatsu

    1. You have access
      HIS-388, a Novel Orally Active and Long-Acting 11β-Hydroxysteroid Dehydrogenase Type 1 Inhibitor, Ameliorates Insulin Sensitivity and Glucose Intolerance in Diet-Induced Obesity and Nongenetic Type 2 Diabetic Murine Models
      Seiji Okazaki, Takehiro Takahashi, Tomokatsu Iwamura, Junko Nakaki, Yumiko Sekiya, Mai Yagi, Hiroki Kumagai, Mikiya Sato, Satoshi Sakami, Aiko Nitta, Koji Kawai and Mie Kainoh
      Journal of Pharmacology and Experimental Therapeutics October 2014, 351 (1) 181-189; DOI: https://doi.org/10.1124/jpet.114.216556

J

  1. Jasper, Jeffrey R.

    1. You have access
      Pharmacologic Characterization of GSK-961081 (TD-5959), a First-in-Class Inhaled Bifunctional Bronchodilator Possessing Muscarinic Receptor Antagonist and β2-Adrenoceptor Agonist Properties
      Sharath S. Hegde, Adam D. Hughes, Yan Chen, Tod Steinfeld, Jeffrey R. Jasper, Tae-Weon Lee, Alexander McNamara, William J. Martin, M. Teresa Pulido-Rios and Mathai Mammen
      Journal of Pharmacology and Experimental Therapeutics October 2014, 351 (1) 190-199; DOI: https://doi.org/10.1124/jpet.114.216861
  2. Jin, X.

    1. You have access
      Perampanel, an Antagonist of α-Amino-3-Hydroxy-5-Methyl-4-Isoxazolepropionic Acid Receptors, for the Treatment of Epilepsy: Studies in Human Epileptic Brain and Nonepileptic Brain and in Rodent Models
      R. Zwart, E. Sher, X. Ping, X. Jin, J. R. Sims, A. S. Chappell, S. D. Gleason, P. J. Hahn, K. Gardinier, D. L. Gernert, J. Hobbs, J. L. Smith, S. N. Valli and J. M. Witkin
      Journal of Pharmacology and Experimental Therapeutics October 2014, 351 (1) 124-133; DOI: https://doi.org/10.1124/jpet.114.212779
  3. Johnstone, Cameron N.

    1. You have access
      Resolvin D2 Supports MCF-7 Cell Proliferation via Activation of Estrogen Receptor
      Nuha Al-Zaubai, Cameron N. Johnstone, May May Leong, John Li, Mark Rizzacasa and Alastair G. Stewart
      Journal of Pharmacology and Experimental Therapeutics October 2014, 351 (1) 172-180; DOI: https://doi.org/10.1124/jpet.114.214403

K

  1. Kabanov, Alexander V.

    1. You have access
      Intranasal Administration as a Route for Drug Delivery to the Brain: Evidence for a Unique Pathway for Albumin
      Joseph A. Falcone, Therese S. Salameh, Xiang Yi, Benjamin J. Cordy, William G. Mortell, Alexander V. Kabanov and William A. Banks
      Journal of Pharmacology and Experimental Therapeutics October 2014, 351 (1) 54-60; DOI: https://doi.org/10.1124/jpet.114.216705
  2. Kainoh, Mie

    1. You have access
      HIS-388, a Novel Orally Active and Long-Acting 11β-Hydroxysteroid Dehydrogenase Type 1 Inhibitor, Ameliorates Insulin Sensitivity and Glucose Intolerance in Diet-Induced Obesity and Nongenetic Type 2 Diabetic Murine Models
      Seiji Okazaki, Takehiro Takahashi, Tomokatsu Iwamura, Junko Nakaki, Yumiko Sekiya, Mai Yagi, Hiroki Kumagai, Mikiya Sato, Satoshi Sakami, Aiko Nitta, Koji Kawai and Mie Kainoh
      Journal of Pharmacology and Experimental Therapeutics October 2014, 351 (1) 181-189; DOI: https://doi.org/10.1124/jpet.114.216556
  3. Kasono, Keizo

    1. You have access
      Two Types of Overcontraction Are Involved in Intrarenal Artery Dysfunction in Type II Diabetic Mouse
      Koji Nobe, Yasuhiro Takenouchi, Keizo Kasono, Terumasa Hashimoto and Kazuo Honda
      Journal of Pharmacology and Experimental Therapeutics October 2014, 351 (1) 77-86; DOI: https://doi.org/10.1124/jpet.114.216747
  4. Kawahigashi, Yumi

    1. You have access
      Development of an Anti–Claudin-3 and -4 Bispecific Monoclonal Antibody for Cancer Diagnosis and Therapy
      Xiangru Li, Manami Iida, Minoru Tada, Akihiro Watari, Yumi Kawahigashi, Yuka Kimura, Taku Yamashita, Akiko Ishii-Watabe, Tadayuki Uno, Masayoshi Fukasawa, Hiroki Kuniyasu, Kiyohito Yagi and Masuo Kondoh
      Journal of Pharmacology and Experimental Therapeutics October 2014, 351 (1) 206-213; DOI: https://doi.org/10.1124/jpet.114.216911
  5. Kawai, Koji

    1. You have access
      HIS-388, a Novel Orally Active and Long-Acting 11β-Hydroxysteroid Dehydrogenase Type 1 Inhibitor, Ameliorates Insulin Sensitivity and Glucose Intolerance in Diet-Induced Obesity and Nongenetic Type 2 Diabetic Murine Models
      Seiji Okazaki, Takehiro Takahashi, Tomokatsu Iwamura, Junko Nakaki, Yumiko Sekiya, Mai Yagi, Hiroki Kumagai, Mikiya Sato, Satoshi Sakami, Aiko Nitta, Koji Kawai and Mie Kainoh
      Journal of Pharmacology and Experimental Therapeutics October 2014, 351 (1) 181-189; DOI: https://doi.org/10.1124/jpet.114.216556
  6. Kerr, Paul M.

    1. You have access
      Modulation of Resistance Artery Tone by the Trace Amine β-Phenylethylamine: Dual Indirect Sympathomimetic and α1-Adrenoceptor Blocking Actions
      Deepak Narang, Paul M. Kerr, Stephanie E. Lunn, Rhys Beaudry, Julie Sigurdson, Margaret D. Lalies, Alan L. Hudson, Peter E. Light, Andrew Holt and Frances Plane
      Journal of Pharmacology and Experimental Therapeutics October 2014, 351 (1) 164-171; DOI: https://doi.org/10.1124/jpet.114.216523
  7. Kimoto, Emi

    1. You have access
      Quantitative Prediction of Transporter- and Enzyme-Mediated Clinical Drug-Drug Interactions of Organic Anion-Transporting Polypeptide 1B1 Substrates Using a Mechanistic Net-Effect Model
      Manthena V. Varma, Yi-an Bi, Emi Kimoto and Jian Lin
      Journal of Pharmacology and Experimental Therapeutics October 2014, 351 (1) 214-223; DOI: https://doi.org/10.1124/jpet.114.215970
  8. Kimura, Yuka

    1. You have access
      Development of an Anti–Claudin-3 and -4 Bispecific Monoclonal Antibody for Cancer Diagnosis and Therapy
      Xiangru Li, Manami Iida, Minoru Tada, Akihiro Watari, Yumi Kawahigashi, Yuka Kimura, Taku Yamashita, Akiko Ishii-Watabe, Tadayuki Uno, Masayoshi Fukasawa, Hiroki Kuniyasu, Kiyohito Yagi and Masuo Kondoh
      Journal of Pharmacology and Experimental Therapeutics October 2014, 351 (1) 206-213; DOI: https://doi.org/10.1124/jpet.114.216911
  9. Klaassen, Curtis D.

    1. You have access
      Decreased Bile-Acid Synthesis in Livers of Hepatocyte-Conditional NADPH–Cytochrome P450 Reductase–Null Mice Results in Increased Bile Acids in Serum
      Xingguo Cheng, Youcai Zhang and Curtis D. Klaassen
      Journal of Pharmacology and Experimental Therapeutics October 2014, 351 (1) 105-113; DOI: https://doi.org/10.1124/jpet.114.216796
  10. Kondoh, Masuo

    1. You have access
      Development of an Anti–Claudin-3 and -4 Bispecific Monoclonal Antibody for Cancer Diagnosis and Therapy
      Xiangru Li, Manami Iida, Minoru Tada, Akihiro Watari, Yumi Kawahigashi, Yuka Kimura, Taku Yamashita, Akiko Ishii-Watabe, Tadayuki Uno, Masayoshi Fukasawa, Hiroki Kuniyasu, Kiyohito Yagi and Masuo Kondoh
      Journal of Pharmacology and Experimental Therapeutics October 2014, 351 (1) 206-213; DOI: https://doi.org/10.1124/jpet.114.216911
  11. Kumagai, Hiroki

    1. You have access
      HIS-388, a Novel Orally Active and Long-Acting 11β-Hydroxysteroid Dehydrogenase Type 1 Inhibitor, Ameliorates Insulin Sensitivity and Glucose Intolerance in Diet-Induced Obesity and Nongenetic Type 2 Diabetic Murine Models
      Seiji Okazaki, Takehiro Takahashi, Tomokatsu Iwamura, Junko Nakaki, Yumiko Sekiya, Mai Yagi, Hiroki Kumagai, Mikiya Sato, Satoshi Sakami, Aiko Nitta, Koji Kawai and Mie Kainoh
      Journal of Pharmacology and Experimental Therapeutics October 2014, 351 (1) 181-189; DOI: https://doi.org/10.1124/jpet.114.216556
  12. Kuniyasu, Hiroki

    1. You have access
      Development of an Anti–Claudin-3 and -4 Bispecific Monoclonal Antibody for Cancer Diagnosis and Therapy
      Xiangru Li, Manami Iida, Minoru Tada, Akihiro Watari, Yumi Kawahigashi, Yuka Kimura, Taku Yamashita, Akiko Ishii-Watabe, Tadayuki Uno, Masayoshi Fukasawa, Hiroki Kuniyasu, Kiyohito Yagi and Masuo Kondoh
      Journal of Pharmacology and Experimental Therapeutics October 2014, 351 (1) 206-213; DOI: https://doi.org/10.1124/jpet.114.216911

L

  1. Lalies, Margaret D.

    1. You have access
      Modulation of Resistance Artery Tone by the Trace Amine β-Phenylethylamine: Dual Indirect Sympathomimetic and α1-Adrenoceptor Blocking Actions
      Deepak Narang, Paul M. Kerr, Stephanie E. Lunn, Rhys Beaudry, Julie Sigurdson, Margaret D. Lalies, Alan L. Hudson, Peter E. Light, Andrew Holt and Frances Plane
      Journal of Pharmacology and Experimental Therapeutics October 2014, 351 (1) 164-171; DOI: https://doi.org/10.1124/jpet.114.216523
  2. Lam, Justine L.

    1. You have access
      Translational Pharmacokinetic-Pharmacodynamic Modeling for an Orally Available Novel Inhibitor of Anaplastic Lymphoma Kinase and c-Ros Oncogene 1
      Shinji Yamazaki, Justine L. Lam, Helen Y. Zou, Hui Wang, Tod Smeal and Paolo Vicini
      Journal of Pharmacology and Experimental Therapeutics October 2014, 351 (1) 67-76; DOI: https://doi.org/10.1124/jpet.114.217141
  3. Leánez, Sergi

    1. You have access
      Treatment with a Heme Oxygenase 1 Inducer Enhances the Antinociceptive Effects of µ-Opioid, δ-Opioid, and Cannabinoid 2 Receptors during Inflammatory Pain
      Mireia Carcolé, Sílvia Castany, Sergi Leánez and Olga Pol
      Journal of Pharmacology and Experimental Therapeutics October 2014, 351 (1) 224-232; DOI: https://doi.org/10.1124/jpet.114.215681
  4. Lee, Sang-Min

    1. You have access
      Dopamine D1 Receptor Signaling: Does GαQ–Phospholipase C Actually Play a Role?
      Sang-Min Lee, Yang Yang and Richard B. Mailman
      Journal of Pharmacology and Experimental Therapeutics October 2014, 351 (1) 9-17; DOI: https://doi.org/10.1124/jpet.114.214411
  5. Lee, Tae-Weon

    1. You have access
      Pharmacologic Characterization of GSK-961081 (TD-5959), a First-in-Class Inhaled Bifunctional Bronchodilator Possessing Muscarinic Receptor Antagonist and β2-Adrenoceptor Agonist Properties
      Sharath S. Hegde, Adam D. Hughes, Yan Chen, Tod Steinfeld, Jeffrey R. Jasper, Tae-Weon Lee, Alexander McNamara, William J. Martin, M. Teresa Pulido-Rios and Mathai Mammen
      Journal of Pharmacology and Experimental Therapeutics October 2014, 351 (1) 190-199; DOI: https://doi.org/10.1124/jpet.114.216861
  6. Leong, May May

    1. You have access
      Resolvin D2 Supports MCF-7 Cell Proliferation via Activation of Estrogen Receptor
      Nuha Al-Zaubai, Cameron N. Johnstone, May May Leong, John Li, Mark Rizzacasa and Alastair G. Stewart
      Journal of Pharmacology and Experimental Therapeutics October 2014, 351 (1) 172-180; DOI: https://doi.org/10.1124/jpet.114.214403
  7. Lever, John R.

    1. You have access
      Relationship between Cerebral Sigma-1 Receptor Occupancy and Attenuation of Cocaine’s Motor Stimulatory Effects in Mice by PD144418
      John R. Lever, Dennis K. Miller, Emily A. Fergason-Cantrell, Caroline L. Green, Lisa D. Watkinson, Terry L. Carmack and Susan Z. Lever
      Journal of Pharmacology and Experimental Therapeutics October 2014, 351 (1) 153-163; DOI: https://doi.org/10.1124/jpet.114.216671
  8. Lever, Susan Z.

    1. You have access
      Relationship between Cerebral Sigma-1 Receptor Occupancy and Attenuation of Cocaine’s Motor Stimulatory Effects in Mice by PD144418
      John R. Lever, Dennis K. Miller, Emily A. Fergason-Cantrell, Caroline L. Green, Lisa D. Watkinson, Terry L. Carmack and Susan Z. Lever
      Journal of Pharmacology and Experimental Therapeutics October 2014, 351 (1) 153-163; DOI: https://doi.org/10.1124/jpet.114.216671
  9. Li, John

    1. You have access
      Resolvin D2 Supports MCF-7 Cell Proliferation via Activation of Estrogen Receptor
      Nuha Al-Zaubai, Cameron N. Johnstone, May May Leong, John Li, Mark Rizzacasa and Alastair G. Stewart
      Journal of Pharmacology and Experimental Therapeutics October 2014, 351 (1) 172-180; DOI: https://doi.org/10.1124/jpet.114.214403
  10. Li, Xiangru

    1. You have access
      Development of an Anti–Claudin-3 and -4 Bispecific Monoclonal Antibody for Cancer Diagnosis and Therapy
      Xiangru Li, Manami Iida, Minoru Tada, Akihiro Watari, Yumi Kawahigashi, Yuka Kimura, Taku Yamashita, Akiko Ishii-Watabe, Tadayuki Uno, Masayoshi Fukasawa, Hiroki Kuniyasu, Kiyohito Yagi and Masuo Kondoh
      Journal of Pharmacology and Experimental Therapeutics October 2014, 351 (1) 206-213; DOI: https://doi.org/10.1124/jpet.114.216911
  11. Liberati, Anna Marina

    1. You have access
      Pharmacological Modulation of Caspase-8 in Thymus-Related Medical Conditions
      Nicola Pozzesi, Alessandra Fierabracci, Trinh Thy Thuy, Maria Paola Martelli, Anna Marina Liberati, Emira Ayroldi, Carlo Riccardi and Domenico V. Delfino
      Journal of Pharmacology and Experimental Therapeutics October 2014, 351 (1) 18-24; DOI: https://doi.org/10.1124/jpet.114.216572
  12. Light, Peter E.

    1. You have access
      Modulation of Resistance Artery Tone by the Trace Amine β-Phenylethylamine: Dual Indirect Sympathomimetic and α1-Adrenoceptor Blocking Actions
      Deepak Narang, Paul M. Kerr, Stephanie E. Lunn, Rhys Beaudry, Julie Sigurdson, Margaret D. Lalies, Alan L. Hudson, Peter E. Light, Andrew Holt and Frances Plane
      Journal of Pharmacology and Experimental Therapeutics October 2014, 351 (1) 164-171; DOI: https://doi.org/10.1124/jpet.114.216523
  13. Lin, Jian

    1. You have access
      Quantitative Prediction of Transporter- and Enzyme-Mediated Clinical Drug-Drug Interactions of Organic Anion-Transporting Polypeptide 1B1 Substrates Using a Mechanistic Net-Effect Model
      Manthena V. Varma, Yi-an Bi, Emi Kimoto and Jian Lin
      Journal of Pharmacology and Experimental Therapeutics October 2014, 351 (1) 214-223; DOI: https://doi.org/10.1124/jpet.114.215970
  14. Lin, Tzu-Yu

    1. You have access
      Cyclooxygenase 2 Inhibitor Celecoxib Inhibits Glutamate Release by Attenuating the PGE2/EP2 Pathway in Rat Cerebral Cortex Endings
      Tzu-Yu Lin, Cheng-Wei Lu, Chia-Chuan Wang, Shu Kuei Huang and Su-Jane Wang
      Journal of Pharmacology and Experimental Therapeutics October 2014, 351 (1) 134-145; DOI: https://doi.org/10.1124/jpet.114.217372
  15. Liu, Gang

    1. You have access
      Therapeutic Targeting of Src Kinase in Myofibroblast Differentiation and Pulmonary Fibrosis
      Meng Hu, Pulin Che, Xiaosi Han, Guo-Qiang Cai, Gang Liu, Veena Antony, Tracy Luckhardt, Gene P. Siegal, Yong Zhou, Rui-ming Liu, Leena P. Desai, Philip J. O’Reilly, Victor J. Thannickal and Qiang Ding
      Journal of Pharmacology and Experimental Therapeutics October 2014, 351 (1) 87-95; DOI: https://doi.org/10.1124/jpet.114.216044
  16. Liu, Rui-ming

    1. You have access
      Therapeutic Targeting of Src Kinase in Myofibroblast Differentiation and Pulmonary Fibrosis
      Meng Hu, Pulin Che, Xiaosi Han, Guo-Qiang Cai, Gang Liu, Veena Antony, Tracy Luckhardt, Gene P. Siegal, Yong Zhou, Rui-ming Liu, Leena P. Desai, Philip J. O’Reilly, Victor J. Thannickal and Qiang Ding
      Journal of Pharmacology and Experimental Therapeutics October 2014, 351 (1) 87-95; DOI: https://doi.org/10.1124/jpet.114.216044
  17. Lu, Cheng-Wei

    1. You have access
      Cyclooxygenase 2 Inhibitor Celecoxib Inhibits Glutamate Release by Attenuating the PGE2/EP2 Pathway in Rat Cerebral Cortex Endings
      Tzu-Yu Lin, Cheng-Wei Lu, Chia-Chuan Wang, Shu Kuei Huang and Su-Jane Wang
      Journal of Pharmacology and Experimental Therapeutics October 2014, 351 (1) 134-145; DOI: https://doi.org/10.1124/jpet.114.217372
  18. Luckhardt, Tracy

    1. You have access
      Therapeutic Targeting of Src Kinase in Myofibroblast Differentiation and Pulmonary Fibrosis
      Meng Hu, Pulin Che, Xiaosi Han, Guo-Qiang Cai, Gang Liu, Veena Antony, Tracy Luckhardt, Gene P. Siegal, Yong Zhou, Rui-ming Liu, Leena P. Desai, Philip J. O’Reilly, Victor J. Thannickal and Qiang Ding
      Journal of Pharmacology and Experimental Therapeutics October 2014, 351 (1) 87-95; DOI: https://doi.org/10.1124/jpet.114.216044
  19. Lunn, Stephanie E.

    1. You have access
      Modulation of Resistance Artery Tone by the Trace Amine β-Phenylethylamine: Dual Indirect Sympathomimetic and α1-Adrenoceptor Blocking Actions
      Deepak Narang, Paul M. Kerr, Stephanie E. Lunn, Rhys Beaudry, Julie Sigurdson, Margaret D. Lalies, Alan L. Hudson, Peter E. Light, Andrew Holt and Frances Plane
      Journal of Pharmacology and Experimental Therapeutics October 2014, 351 (1) 164-171; DOI: https://doi.org/10.1124/jpet.114.216523

M

  1. Mailman, Richard B.

    1. You have access
      Dopamine D1 Receptor Signaling: Does GαQ–Phospholipase C Actually Play a Role?
      Sang-Min Lee, Yang Yang and Richard B. Mailman
      Journal of Pharmacology and Experimental Therapeutics October 2014, 351 (1) 9-17; DOI: https://doi.org/10.1124/jpet.114.214411
  2. Mammen, Mathai

    1. You have access
      Pharmacologic Characterization of GSK-961081 (TD-5959), a First-in-Class Inhaled Bifunctional Bronchodilator Possessing Muscarinic Receptor Antagonist and β2-Adrenoceptor Agonist Properties
      Sharath S. Hegde, Adam D. Hughes, Yan Chen, Tod Steinfeld, Jeffrey R. Jasper, Tae-Weon Lee, Alexander McNamara, William J. Martin, M. Teresa Pulido-Rios and Mathai Mammen
      Journal of Pharmacology and Experimental Therapeutics October 2014, 351 (1) 190-199; DOI: https://doi.org/10.1124/jpet.114.216861
  3. Mariotta, Luca

    1. You have access
      The Molecular Mechanism of Intestinal Levodopa Absorption and Its Possible Implications for the Treatment of Parkinson’s Disease
      Simone M. R. Camargo, Raphael N. Vuille-dit-Bille, Luca Mariotta, Tamara Ramadan, Katja Huggel, Dustin Singer, Oliver Götze and François Verrey
      Journal of Pharmacology and Experimental Therapeutics October 2014, 351 (1) 114-123; DOI: https://doi.org/10.1124/jpet.114.216317
  4. Martelli, Maria Paola

    1. You have access
      Pharmacological Modulation of Caspase-8 in Thymus-Related Medical Conditions
      Nicola Pozzesi, Alessandra Fierabracci, Trinh Thy Thuy, Maria Paola Martelli, Anna Marina Liberati, Emira Ayroldi, Carlo Riccardi and Domenico V. Delfino
      Journal of Pharmacology and Experimental Therapeutics October 2014, 351 (1) 18-24; DOI: https://doi.org/10.1124/jpet.114.216572
  5. Martin, William J.

    1. You have access
      Pharmacologic Characterization of GSK-961081 (TD-5959), a First-in-Class Inhaled Bifunctional Bronchodilator Possessing Muscarinic Receptor Antagonist and β2-Adrenoceptor Agonist Properties
      Sharath S. Hegde, Adam D. Hughes, Yan Chen, Tod Steinfeld, Jeffrey R. Jasper, Tae-Weon Lee, Alexander McNamara, William J. Martin, M. Teresa Pulido-Rios and Mathai Mammen
      Journal of Pharmacology and Experimental Therapeutics October 2014, 351 (1) 190-199; DOI: https://doi.org/10.1124/jpet.114.216861
  6. Mattheolabakis, George

    1. You have access
      Pegylation Improves the Pharmacokinetics and Bioavailability of Small-Molecule Drugs Hydrolyzable by Esterases: A Study of Phospho-Ibuprofen
      George Mattheolabakis, Chi C. Wong, Yu Sun, Carol A. Amella, Robert Richards, Panayiotis P. Constantinides and Basil Rigas
      Journal of Pharmacology and Experimental Therapeutics October 2014, 351 (1) 61-66; DOI: https://doi.org/10.1124/jpet.114.217208
  7. McGregor, Matthew

    1. You have access
      The α7 Nicotinic Receptor Agonist ABT-107 Decreases l-Dopa–Induced Dyskinesias in Parkinsonian Monkeys
      Danhui Zhang, Matthew McGregor, Michael W. Decker and Maryka Quik
      Journal of Pharmacology and Experimental Therapeutics October 2014, 351 (1) 25-32; DOI: https://doi.org/10.1124/jpet.114.216283
  8. McNamara, Alexander

    1. You have access
      Pharmacologic Characterization of GSK-961081 (TD-5959), a First-in-Class Inhaled Bifunctional Bronchodilator Possessing Muscarinic Receptor Antagonist and β2-Adrenoceptor Agonist Properties
      Sharath S. Hegde, Adam D. Hughes, Yan Chen, Tod Steinfeld, Jeffrey R. Jasper, Tae-Weon Lee, Alexander McNamara, William J. Martin, M. Teresa Pulido-Rios and Mathai Mammen
      Journal of Pharmacology and Experimental Therapeutics October 2014, 351 (1) 190-199; DOI: https://doi.org/10.1124/jpet.114.216861
  9. Miller, Dennis K.

    1. You have access
      Relationship between Cerebral Sigma-1 Receptor Occupancy and Attenuation of Cocaine’s Motor Stimulatory Effects in Mice by PD144418
      John R. Lever, Dennis K. Miller, Emily A. Fergason-Cantrell, Caroline L. Green, Lisa D. Watkinson, Terry L. Carmack and Susan Z. Lever
      Journal of Pharmacology and Experimental Therapeutics October 2014, 351 (1) 153-163; DOI: https://doi.org/10.1124/jpet.114.216671
  10. Mitidieri, Emma

    1. You have access
      Annexin A1 Mediates Hydrogen Sulfide Properties in the Control of Inflammation
      Vincenzo Brancaleone, Emma Mitidieri, Roderick J. Flower, Giuseppe Cirino and Mauro Perretti
      Journal of Pharmacology and Experimental Therapeutics October 2014, 351 (1) 96-104; DOI: https://doi.org/10.1124/jpet.114.217034
  11. Mohammadi, Ehsan

    1. You have access
      Synergistic Effect of 5-Hydroxytryptamine 3 and Neurokinin 1 Receptor Antagonism in Rodent Models of Somatic and Visceral Pain
      Beverley Greenwood-Van Meerveld, Ehsan Mohammadi, Karl Tyler, Claudio Pietra, Lucy A. Bee and Anthony Dickenson
      Journal of Pharmacology and Experimental Therapeutics October 2014, 351 (1) 146-152; DOI: https://doi.org/10.1124/jpet.114.216028
  12. Mortell, William G.

    1. You have access
      Intranasal Administration as a Route for Drug Delivery to the Brain: Evidence for a Unique Pathway for Albumin
      Joseph A. Falcone, Therese S. Salameh, Xiang Yi, Benjamin J. Cordy, William G. Mortell, Alexander V. Kabanov and William A. Banks
      Journal of Pharmacology and Experimental Therapeutics October 2014, 351 (1) 54-60; DOI: https://doi.org/10.1124/jpet.114.216705
  13. Motulsky, Harvey J.

    1. You have access
      Common Misconceptions about Data Analysis and Statistics
      Harvey J. Motulsky
      Journal of Pharmacology and Experimental Therapeutics October 2014, 351 (1) 200-205; DOI: https://doi.org/10.1124/jpet.114.219170

N

  1. Nakaki, Junko

    1. You have access
      HIS-388, a Novel Orally Active and Long-Acting 11β-Hydroxysteroid Dehydrogenase Type 1 Inhibitor, Ameliorates Insulin Sensitivity and Glucose Intolerance in Diet-Induced Obesity and Nongenetic Type 2 Diabetic Murine Models
      Seiji Okazaki, Takehiro Takahashi, Tomokatsu Iwamura, Junko Nakaki, Yumiko Sekiya, Mai Yagi, Hiroki Kumagai, Mikiya Sato, Satoshi Sakami, Aiko Nitta, Koji Kawai and Mie Kainoh
      Journal of Pharmacology and Experimental Therapeutics October 2014, 351 (1) 181-189; DOI: https://doi.org/10.1124/jpet.114.216556
  2. Narang, Deepak

    1. You have access
      Modulation of Resistance Artery Tone by the Trace Amine β-Phenylethylamine: Dual Indirect Sympathomimetic and α1-Adrenoceptor Blocking Actions
      Deepak Narang, Paul M. Kerr, Stephanie E. Lunn, Rhys Beaudry, Julie Sigurdson, Margaret D. Lalies, Alan L. Hudson, Peter E. Light, Andrew Holt and Frances Plane
      Journal of Pharmacology and Experimental Therapeutics October 2014, 351 (1) 164-171; DOI: https://doi.org/10.1124/jpet.114.216523
  3. Nitta, Aiko

    1. You have access
      HIS-388, a Novel Orally Active and Long-Acting 11β-Hydroxysteroid Dehydrogenase Type 1 Inhibitor, Ameliorates Insulin Sensitivity and Glucose Intolerance in Diet-Induced Obesity and Nongenetic Type 2 Diabetic Murine Models
      Seiji Okazaki, Takehiro Takahashi, Tomokatsu Iwamura, Junko Nakaki, Yumiko Sekiya, Mai Yagi, Hiroki Kumagai, Mikiya Sato, Satoshi Sakami, Aiko Nitta, Koji Kawai and Mie Kainoh
      Journal of Pharmacology and Experimental Therapeutics October 2014, 351 (1) 181-189; DOI: https://doi.org/10.1124/jpet.114.216556
  4. Nobe, Koji

    1. You have access
      Two Types of Overcontraction Are Involved in Intrarenal Artery Dysfunction in Type II Diabetic Mouse
      Koji Nobe, Yasuhiro Takenouchi, Keizo Kasono, Terumasa Hashimoto and Kazuo Honda
      Journal of Pharmacology and Experimental Therapeutics October 2014, 351 (1) 77-86; DOI: https://doi.org/10.1124/jpet.114.216747

O

  1. O’Reilly, Philip J.

    1. You have access
      Therapeutic Targeting of Src Kinase in Myofibroblast Differentiation and Pulmonary Fibrosis
      Meng Hu, Pulin Che, Xiaosi Han, Guo-Qiang Cai, Gang Liu, Veena Antony, Tracy Luckhardt, Gene P. Siegal, Yong Zhou, Rui-ming Liu, Leena P. Desai, Philip J. O’Reilly, Victor J. Thannickal and Qiang Ding
      Journal of Pharmacology and Experimental Therapeutics October 2014, 351 (1) 87-95; DOI: https://doi.org/10.1124/jpet.114.216044
  2. Okazaki, Seiji

    1. You have access
      HIS-388, a Novel Orally Active and Long-Acting 11β-Hydroxysteroid Dehydrogenase Type 1 Inhibitor, Ameliorates Insulin Sensitivity and Glucose Intolerance in Diet-Induced Obesity and Nongenetic Type 2 Diabetic Murine Models
      Seiji Okazaki, Takehiro Takahashi, Tomokatsu Iwamura, Junko Nakaki, Yumiko Sekiya, Mai Yagi, Hiroki Kumagai, Mikiya Sato, Satoshi Sakami, Aiko Nitta, Koji Kawai and Mie Kainoh
      Journal of Pharmacology and Experimental Therapeutics October 2014, 351 (1) 181-189; DOI: https://doi.org/10.1124/jpet.114.216556

P

  1. Penumarti, Anusha

    1. You have access
      Neuronal Nitric Oxide Synthase–Dependent Elevation in Adiponectin in the Rostral Ventrolateral Medulla Underlies G Protein–Coupled Receptor 18–Mediated Hypotension in Conscious Rats
      Anusha Penumarti and Abdel A. Abdel-Rahman
      Journal of Pharmacology and Experimental Therapeutics October 2014, 351 (1) 44-53; DOI: https://doi.org/10.1124/jpet.114.216036
  2. Perretti, Mauro

    1. You have access
      Annexin A1 Mediates Hydrogen Sulfide Properties in the Control of Inflammation
      Vincenzo Brancaleone, Emma Mitidieri, Roderick J. Flower, Giuseppe Cirino and Mauro Perretti
      Journal of Pharmacology and Experimental Therapeutics October 2014, 351 (1) 96-104; DOI: https://doi.org/10.1124/jpet.114.217034
  3. Pietra, Claudio

    1. You have access
      Synergistic Effect of 5-Hydroxytryptamine 3 and Neurokinin 1 Receptor Antagonism in Rodent Models of Somatic and Visceral Pain
      Beverley Greenwood-Van Meerveld, Ehsan Mohammadi, Karl Tyler, Claudio Pietra, Lucy A. Bee and Anthony Dickenson
      Journal of Pharmacology and Experimental Therapeutics October 2014, 351 (1) 146-152; DOI: https://doi.org/10.1124/jpet.114.216028
  4. Ping, X.

    1. You have access
      Perampanel, an Antagonist of α-Amino-3-Hydroxy-5-Methyl-4-Isoxazolepropionic Acid Receptors, for the Treatment of Epilepsy: Studies in Human Epileptic Brain and Nonepileptic Brain and in Rodent Models
      R. Zwart, E. Sher, X. Ping, X. Jin, J. R. Sims, A. S. Chappell, S. D. Gleason, P. J. Hahn, K. Gardinier, D. L. Gernert, J. Hobbs, J. L. Smith, S. N. Valli and J. M. Witkin
      Journal of Pharmacology and Experimental Therapeutics October 2014, 351 (1) 124-133; DOI: https://doi.org/10.1124/jpet.114.212779
  5. Plane, Frances

    1. You have access
      Modulation of Resistance Artery Tone by the Trace Amine β-Phenylethylamine: Dual Indirect Sympathomimetic and α1-Adrenoceptor Blocking Actions
      Deepak Narang, Paul M. Kerr, Stephanie E. Lunn, Rhys Beaudry, Julie Sigurdson, Margaret D. Lalies, Alan L. Hudson, Peter E. Light, Andrew Holt and Frances Plane
      Journal of Pharmacology and Experimental Therapeutics October 2014, 351 (1) 164-171; DOI: https://doi.org/10.1124/jpet.114.216523
  6. Pol, Olga

    1. You have access
      Treatment with a Heme Oxygenase 1 Inducer Enhances the Antinociceptive Effects of µ-Opioid, δ-Opioid, and Cannabinoid 2 Receptors during Inflammatory Pain
      Mireia Carcolé, Sílvia Castany, Sergi Leánez and Olga Pol
      Journal of Pharmacology and Experimental Therapeutics October 2014, 351 (1) 224-232; DOI: https://doi.org/10.1124/jpet.114.215681
  7. Pozzesi, Nicola

    1. You have access
      Pharmacological Modulation of Caspase-8 in Thymus-Related Medical Conditions
      Nicola Pozzesi, Alessandra Fierabracci, Trinh Thy Thuy, Maria Paola Martelli, Anna Marina Liberati, Emira Ayroldi, Carlo Riccardi and Domenico V. Delfino
      Journal of Pharmacology and Experimental Therapeutics October 2014, 351 (1) 18-24; DOI: https://doi.org/10.1124/jpet.114.216572
  8. Pulido-Rios, M. Teresa

    1. You have access
      Pharmacologic Characterization of GSK-961081 (TD-5959), a First-in-Class Inhaled Bifunctional Bronchodilator Possessing Muscarinic Receptor Antagonist and β2-Adrenoceptor Agonist Properties
      Sharath S. Hegde, Adam D. Hughes, Yan Chen, Tod Steinfeld, Jeffrey R. Jasper, Tae-Weon Lee, Alexander McNamara, William J. Martin, M. Teresa Pulido-Rios and Mathai Mammen
      Journal of Pharmacology and Experimental Therapeutics October 2014, 351 (1) 190-199; DOI: https://doi.org/10.1124/jpet.114.216861

Q

  1. Quik, Maryka

    1. You have access
      The α7 Nicotinic Receptor Agonist ABT-107 Decreases l-Dopa–Induced Dyskinesias in Parkinsonian Monkeys
      Danhui Zhang, Matthew McGregor, Michael W. Decker and Maryka Quik
      Journal of Pharmacology and Experimental Therapeutics October 2014, 351 (1) 25-32; DOI: https://doi.org/10.1124/jpet.114.216283

R

  1. Ramadan, Tamara

    1. You have access
      The Molecular Mechanism of Intestinal Levodopa Absorption and Its Possible Implications for the Treatment of Parkinson’s Disease
      Simone M. R. Camargo, Raphael N. Vuille-dit-Bille, Luca Mariotta, Tamara Ramadan, Katja Huggel, Dustin Singer, Oliver Götze and François Verrey
      Journal of Pharmacology and Experimental Therapeutics October 2014, 351 (1) 114-123; DOI: https://doi.org/10.1124/jpet.114.216317
  2. Riccardi, Carlo

    1. You have access
      Pharmacological Modulation of Caspase-8 in Thymus-Related Medical Conditions
      Nicola Pozzesi, Alessandra Fierabracci, Trinh Thy Thuy, Maria Paola Martelli, Anna Marina Liberati, Emira Ayroldi, Carlo Riccardi and Domenico V. Delfino
      Journal of Pharmacology and Experimental Therapeutics October 2014, 351 (1) 18-24; DOI: https://doi.org/10.1124/jpet.114.216572
  3. Richards, Robert

    1. You have access
      Pegylation Improves the Pharmacokinetics and Bioavailability of Small-Molecule Drugs Hydrolyzable by Esterases: A Study of Phospho-Ibuprofen
      George Mattheolabakis, Chi C. Wong, Yu Sun, Carol A. Amella, Robert Richards, Panayiotis P. Constantinides and Basil Rigas
      Journal of Pharmacology and Experimental Therapeutics October 2014, 351 (1) 61-66; DOI: https://doi.org/10.1124/jpet.114.217208
  4. Rigas, Basil

    1. You have access
      Pegylation Improves the Pharmacokinetics and Bioavailability of Small-Molecule Drugs Hydrolyzable by Esterases: A Study of Phospho-Ibuprofen
      George Mattheolabakis, Chi C. Wong, Yu Sun, Carol A. Amella, Robert Richards, Panayiotis P. Constantinides and Basil Rigas
      Journal of Pharmacology and Experimental Therapeutics October 2014, 351 (1) 61-66; DOI: https://doi.org/10.1124/jpet.114.217208
  5. Rizzacasa, Mark

    1. You have access
      Resolvin D2 Supports MCF-7 Cell Proliferation via Activation of Estrogen Receptor
      Nuha Al-Zaubai, Cameron N. Johnstone, May May Leong, John Li, Mark Rizzacasa and Alastair G. Stewart
      Journal of Pharmacology and Experimental Therapeutics October 2014, 351 (1) 172-180; DOI: https://doi.org/10.1124/jpet.114.214403

S

  1. Sakami, Satoshi

    1. You have access
      HIS-388, a Novel Orally Active and Long-Acting 11β-Hydroxysteroid Dehydrogenase Type 1 Inhibitor, Ameliorates Insulin Sensitivity and Glucose Intolerance in Diet-Induced Obesity and Nongenetic Type 2 Diabetic Murine Models
      Seiji Okazaki, Takehiro Takahashi, Tomokatsu Iwamura, Junko Nakaki, Yumiko Sekiya, Mai Yagi, Hiroki Kumagai, Mikiya Sato, Satoshi Sakami, Aiko Nitta, Koji Kawai and Mie Kainoh
      Journal of Pharmacology and Experimental Therapeutics October 2014, 351 (1) 181-189; DOI: https://doi.org/10.1124/jpet.114.216556
  2. Salameh, Therese S.

    1. You have access
      Intranasal Administration as a Route for Drug Delivery to the Brain: Evidence for a Unique Pathway for Albumin
      Joseph A. Falcone, Therese S. Salameh, Xiang Yi, Benjamin J. Cordy, William G. Mortell, Alexander V. Kabanov and William A. Banks
      Journal of Pharmacology and Experimental Therapeutics October 2014, 351 (1) 54-60; DOI: https://doi.org/10.1124/jpet.114.216705
  3. Sato, Mikiya

    1. You have access
      HIS-388, a Novel Orally Active and Long-Acting 11β-Hydroxysteroid Dehydrogenase Type 1 Inhibitor, Ameliorates Insulin Sensitivity and Glucose Intolerance in Diet-Induced Obesity and Nongenetic Type 2 Diabetic Murine Models
      Seiji Okazaki, Takehiro Takahashi, Tomokatsu Iwamura, Junko Nakaki, Yumiko Sekiya, Mai Yagi, Hiroki Kumagai, Mikiya Sato, Satoshi Sakami, Aiko Nitta, Koji Kawai and Mie Kainoh
      Journal of Pharmacology and Experimental Therapeutics October 2014, 351 (1) 181-189; DOI: https://doi.org/10.1124/jpet.114.216556
  4. Schank, Jesse R.

    1. You have access
      The Neurokinin-1 Receptor in Addictive Processes
      Jesse R. Schank
      Journal of Pharmacology and Experimental Therapeutics October 2014, 351 (1) 2-8; DOI: https://doi.org/10.1124/jpet.113.210799
  5. Sekiya, Yumiko

    1. You have access
      HIS-388, a Novel Orally Active and Long-Acting 11β-Hydroxysteroid Dehydrogenase Type 1 Inhibitor, Ameliorates Insulin Sensitivity and Glucose Intolerance in Diet-Induced Obesity and Nongenetic Type 2 Diabetic Murine Models
      Seiji Okazaki, Takehiro Takahashi, Tomokatsu Iwamura, Junko Nakaki, Yumiko Sekiya, Mai Yagi, Hiroki Kumagai, Mikiya Sato, Satoshi Sakami, Aiko Nitta, Koji Kawai and Mie Kainoh
      Journal of Pharmacology and Experimental Therapeutics October 2014, 351 (1) 181-189; DOI: https://doi.org/10.1124/jpet.114.216556
  6. Sher, E.

    1. You have access
      Perampanel, an Antagonist of α-Amino-3-Hydroxy-5-Methyl-4-Isoxazolepropionic Acid Receptors, for the Treatment of Epilepsy: Studies in Human Epileptic Brain and Nonepileptic Brain and in Rodent Models
      R. Zwart, E. Sher, X. Ping, X. Jin, J. R. Sims, A. S. Chappell, S. D. Gleason, P. J. Hahn, K. Gardinier, D. L. Gernert, J. Hobbs, J. L. Smith, S. N. Valli and J. M. Witkin
      Journal of Pharmacology and Experimental Therapeutics October 2014, 351 (1) 124-133; DOI: https://doi.org/10.1124/jpet.114.212779
  7. Siegal, Gene P.

    1. You have access
      Therapeutic Targeting of Src Kinase in Myofibroblast Differentiation and Pulmonary Fibrosis
      Meng Hu, Pulin Che, Xiaosi Han, Guo-Qiang Cai, Gang Liu, Veena Antony, Tracy Luckhardt, Gene P. Siegal, Yong Zhou, Rui-ming Liu, Leena P. Desai, Philip J. O’Reilly, Victor J. Thannickal and Qiang Ding
      Journal of Pharmacology and Experimental Therapeutics October 2014, 351 (1) 87-95; DOI: https://doi.org/10.1124/jpet.114.216044
  8. Sigurdson, Julie

    1. You have access
      Modulation of Resistance Artery Tone by the Trace Amine β-Phenylethylamine: Dual Indirect Sympathomimetic and α1-Adrenoceptor Blocking Actions
      Deepak Narang, Paul M. Kerr, Stephanie E. Lunn, Rhys Beaudry, Julie Sigurdson, Margaret D. Lalies, Alan L. Hudson, Peter E. Light, Andrew Holt and Frances Plane
      Journal of Pharmacology and Experimental Therapeutics October 2014, 351 (1) 164-171; DOI: https://doi.org/10.1124/jpet.114.216523
  9. Sims, J. R.

    1. You have access
      Perampanel, an Antagonist of α-Amino-3-Hydroxy-5-Methyl-4-Isoxazolepropionic Acid Receptors, for the Treatment of Epilepsy: Studies in Human Epileptic Brain and Nonepileptic Brain and in Rodent Models
      R. Zwart, E. Sher, X. Ping, X. Jin, J. R. Sims, A. S. Chappell, S. D. Gleason, P. J. Hahn, K. Gardinier, D. L. Gernert, J. Hobbs, J. L. Smith, S. N. Valli and J. M. Witkin
      Journal of Pharmacology and Experimental Therapeutics October 2014, 351 (1) 124-133; DOI: https://doi.org/10.1124/jpet.114.212779
  10. Singer, Dustin

    1. You have access
      The Molecular Mechanism of Intestinal Levodopa Absorption and Its Possible Implications for the Treatment of Parkinson’s Disease
      Simone M. R. Camargo, Raphael N. Vuille-dit-Bille, Luca Mariotta, Tamara Ramadan, Katja Huggel, Dustin Singer, Oliver Götze and François Verrey
      Journal of Pharmacology and Experimental Therapeutics October 2014, 351 (1) 114-123; DOI: https://doi.org/10.1124/jpet.114.216317
  11. Smeal, Tod

    1. You have access
      Translational Pharmacokinetic-Pharmacodynamic Modeling for an Orally Available Novel Inhibitor of Anaplastic Lymphoma Kinase and c-Ros Oncogene 1
      Shinji Yamazaki, Justine L. Lam, Helen Y. Zou, Hui Wang, Tod Smeal and Paolo Vicini
      Journal of Pharmacology and Experimental Therapeutics October 2014, 351 (1) 67-76; DOI: https://doi.org/10.1124/jpet.114.217141
  12. Smith, J. L.

    1. You have access
      Perampanel, an Antagonist of α-Amino-3-Hydroxy-5-Methyl-4-Isoxazolepropionic Acid Receptors, for the Treatment of Epilepsy: Studies in Human Epileptic Brain and Nonepileptic Brain and in Rodent Models
      R. Zwart, E. Sher, X. Ping, X. Jin, J. R. Sims, A. S. Chappell, S. D. Gleason, P. J. Hahn, K. Gardinier, D. L. Gernert, J. Hobbs, J. L. Smith, S. N. Valli and J. M. Witkin
      Journal of Pharmacology and Experimental Therapeutics October 2014, 351 (1) 124-133; DOI: https://doi.org/10.1124/jpet.114.212779
  13. Song, Yanna

    1. You have access
      Racial Differences in Resistance to P2Y12 Receptor Antagonists in Type 2 Diabetic Subjects
      John H. Cleator, Matthew T. Duvernay, Michael Holinstat, Nancy E. Colowick, Willie J. Hudson, Yanna Song, Frank E. Harrell and Heidi E. Hamm
      Journal of Pharmacology and Experimental Therapeutics October 2014, 351 (1) 33-43; DOI: https://doi.org/10.1124/jpet.114.215616
  14. Steinfeld, Tod

    1. You have access
      Pharmacologic Characterization of GSK-961081 (TD-5959), a First-in-Class Inhaled Bifunctional Bronchodilator Possessing Muscarinic Receptor Antagonist and β2-Adrenoceptor Agonist Properties
      Sharath S. Hegde, Adam D. Hughes, Yan Chen, Tod Steinfeld, Jeffrey R. Jasper, Tae-Weon Lee, Alexander McNamara, William J. Martin, M. Teresa Pulido-Rios and Mathai Mammen
      Journal of Pharmacology and Experimental Therapeutics October 2014, 351 (1) 190-199; DOI: https://doi.org/10.1124/jpet.114.216861
  15. Stewart, Alastair G.

    1. You have access
      Resolvin D2 Supports MCF-7 Cell Proliferation via Activation of Estrogen Receptor
      Nuha Al-Zaubai, Cameron N. Johnstone, May May Leong, John Li, Mark Rizzacasa and Alastair G. Stewart
      Journal of Pharmacology and Experimental Therapeutics October 2014, 351 (1) 172-180; DOI: https://doi.org/10.1124/jpet.114.214403
  16. Sun, Yu

    1. You have access
      Pegylation Improves the Pharmacokinetics and Bioavailability of Small-Molecule Drugs Hydrolyzable by Esterases: A Study of Phospho-Ibuprofen
      George Mattheolabakis, Chi C. Wong, Yu Sun, Carol A. Amella, Robert Richards, Panayiotis P. Constantinides and Basil Rigas
      Journal of Pharmacology and Experimental Therapeutics October 2014, 351 (1) 61-66; DOI: https://doi.org/10.1124/jpet.114.217208

T

  1. Tada, Minoru

    1. You have access
      Development of an Anti–Claudin-3 and -4 Bispecific Monoclonal Antibody for Cancer Diagnosis and Therapy
      Xiangru Li, Manami Iida, Minoru Tada, Akihiro Watari, Yumi Kawahigashi, Yuka Kimura, Taku Yamashita, Akiko Ishii-Watabe, Tadayuki Uno, Masayoshi Fukasawa, Hiroki Kuniyasu, Kiyohito Yagi and Masuo Kondoh
      Journal of Pharmacology and Experimental Therapeutics October 2014, 351 (1) 206-213; DOI: https://doi.org/10.1124/jpet.114.216911
  2. Takahashi, Takehiro

    1. You have access
      HIS-388, a Novel Orally Active and Long-Acting 11β-Hydroxysteroid Dehydrogenase Type 1 Inhibitor, Ameliorates Insulin Sensitivity and Glucose Intolerance in Diet-Induced Obesity and Nongenetic Type 2 Diabetic Murine Models
      Seiji Okazaki, Takehiro Takahashi, Tomokatsu Iwamura, Junko Nakaki, Yumiko Sekiya, Mai Yagi, Hiroki Kumagai, Mikiya Sato, Satoshi Sakami, Aiko Nitta, Koji Kawai and Mie Kainoh
      Journal of Pharmacology and Experimental Therapeutics October 2014, 351 (1) 181-189; DOI: https://doi.org/10.1124/jpet.114.216556
  3. Takenouchi, Yasuhiro

    1. You have access
      Two Types of Overcontraction Are Involved in Intrarenal Artery Dysfunction in Type II Diabetic Mouse
      Koji Nobe, Yasuhiro Takenouchi, Keizo Kasono, Terumasa Hashimoto and Kazuo Honda
      Journal of Pharmacology and Experimental Therapeutics October 2014, 351 (1) 77-86; DOI: https://doi.org/10.1124/jpet.114.216747
  4. Thannickal, Victor J.

    1. You have access
      Therapeutic Targeting of Src Kinase in Myofibroblast Differentiation and Pulmonary Fibrosis
      Meng Hu, Pulin Che, Xiaosi Han, Guo-Qiang Cai, Gang Liu, Veena Antony, Tracy Luckhardt, Gene P. Siegal, Yong Zhou, Rui-ming Liu, Leena P. Desai, Philip J. O’Reilly, Victor J. Thannickal and Qiang Ding
      Journal of Pharmacology and Experimental Therapeutics October 2014, 351 (1) 87-95; DOI: https://doi.org/10.1124/jpet.114.216044
  5. Thuy, Trinh Thy

    1. You have access
      Pharmacological Modulation of Caspase-8 in Thymus-Related Medical Conditions
      Nicola Pozzesi, Alessandra Fierabracci, Trinh Thy Thuy, Maria Paola Martelli, Anna Marina Liberati, Emira Ayroldi, Carlo Riccardi and Domenico V. Delfino
      Journal of Pharmacology and Experimental Therapeutics October 2014, 351 (1) 18-24; DOI: https://doi.org/10.1124/jpet.114.216572
  6. Tyler, Karl

    1. You have access
      Synergistic Effect of 5-Hydroxytryptamine 3 and Neurokinin 1 Receptor Antagonism in Rodent Models of Somatic and Visceral Pain
      Beverley Greenwood-Van Meerveld, Ehsan Mohammadi, Karl Tyler, Claudio Pietra, Lucy A. Bee and Anthony Dickenson
      Journal of Pharmacology and Experimental Therapeutics October 2014, 351 (1) 146-152; DOI: https://doi.org/10.1124/jpet.114.216028

U

  1. Uno, Tadayuki

    1. You have access
      Development of an Anti–Claudin-3 and -4 Bispecific Monoclonal Antibody for Cancer Diagnosis and Therapy
      Xiangru Li, Manami Iida, Minoru Tada, Akihiro Watari, Yumi Kawahigashi, Yuka Kimura, Taku Yamashita, Akiko Ishii-Watabe, Tadayuki Uno, Masayoshi Fukasawa, Hiroki Kuniyasu, Kiyohito Yagi and Masuo Kondoh
      Journal of Pharmacology and Experimental Therapeutics October 2014, 351 (1) 206-213; DOI: https://doi.org/10.1124/jpet.114.216911

V

  1. Valli, S. N.

    1. You have access
      Perampanel, an Antagonist of α-Amino-3-Hydroxy-5-Methyl-4-Isoxazolepropionic Acid Receptors, for the Treatment of Epilepsy: Studies in Human Epileptic Brain and Nonepileptic Brain and in Rodent Models
      R. Zwart, E. Sher, X. Ping, X. Jin, J. R. Sims, A. S. Chappell, S. D. Gleason, P. J. Hahn, K. Gardinier, D. L. Gernert, J. Hobbs, J. L. Smith, S. N. Valli and J. M. Witkin
      Journal of Pharmacology and Experimental Therapeutics October 2014, 351 (1) 124-133; DOI: https://doi.org/10.1124/jpet.114.212779
  2. Varma, Manthena V.

    1. You have access
      Quantitative Prediction of Transporter- and Enzyme-Mediated Clinical Drug-Drug Interactions of Organic Anion-Transporting Polypeptide 1B1 Substrates Using a Mechanistic Net-Effect Model
      Manthena V. Varma, Yi-an Bi, Emi Kimoto and Jian Lin
      Journal of Pharmacology and Experimental Therapeutics October 2014, 351 (1) 214-223; DOI: https://doi.org/10.1124/jpet.114.215970
  3. Verrey, François

    1. You have access
      The Molecular Mechanism of Intestinal Levodopa Absorption and Its Possible Implications for the Treatment of Parkinson’s Disease
      Simone M. R. Camargo, Raphael N. Vuille-dit-Bille, Luca Mariotta, Tamara Ramadan, Katja Huggel, Dustin Singer, Oliver Götze and François Verrey
      Journal of Pharmacology and Experimental Therapeutics October 2014, 351 (1) 114-123; DOI: https://doi.org/10.1124/jpet.114.216317
  4. Vicini, Paolo

    1. You have access
      Translational Pharmacokinetic-Pharmacodynamic Modeling for an Orally Available Novel Inhibitor of Anaplastic Lymphoma Kinase and c-Ros Oncogene 1
      Shinji Yamazaki, Justine L. Lam, Helen Y. Zou, Hui Wang, Tod Smeal and Paolo Vicini
      Journal of Pharmacology and Experimental Therapeutics October 2014, 351 (1) 67-76; DOI: https://doi.org/10.1124/jpet.114.217141
  5. Vuille-dit-Bille, Raphael N.

    1. You have access
      The Molecular Mechanism of Intestinal Levodopa Absorption and Its Possible Implications for the Treatment of Parkinson’s Disease
      Simone M. R. Camargo, Raphael N. Vuille-dit-Bille, Luca Mariotta, Tamara Ramadan, Katja Huggel, Dustin Singer, Oliver Götze and François Verrey
      Journal of Pharmacology and Experimental Therapeutics October 2014, 351 (1) 114-123; DOI: https://doi.org/10.1124/jpet.114.216317

W

  1. Wang, Chia-Chuan

    1. You have access
      Cyclooxygenase 2 Inhibitor Celecoxib Inhibits Glutamate Release by Attenuating the PGE2/EP2 Pathway in Rat Cerebral Cortex Endings
      Tzu-Yu Lin, Cheng-Wei Lu, Chia-Chuan Wang, Shu Kuei Huang and Su-Jane Wang
      Journal of Pharmacology and Experimental Therapeutics October 2014, 351 (1) 134-145; DOI: https://doi.org/10.1124/jpet.114.217372
  2. Wang, Hui

    1. You have access
      Translational Pharmacokinetic-Pharmacodynamic Modeling for an Orally Available Novel Inhibitor of Anaplastic Lymphoma Kinase and c-Ros Oncogene 1
      Shinji Yamazaki, Justine L. Lam, Helen Y. Zou, Hui Wang, Tod Smeal and Paolo Vicini
      Journal of Pharmacology and Experimental Therapeutics October 2014, 351 (1) 67-76; DOI: https://doi.org/10.1124/jpet.114.217141
  3. Wang, Su-Jane

    1. You have access
      Cyclooxygenase 2 Inhibitor Celecoxib Inhibits Glutamate Release by Attenuating the PGE2/EP2 Pathway in Rat Cerebral Cortex Endings
      Tzu-Yu Lin, Cheng-Wei Lu, Chia-Chuan Wang, Shu Kuei Huang and Su-Jane Wang
      Journal of Pharmacology and Experimental Therapeutics October 2014, 351 (1) 134-145; DOI: https://doi.org/10.1124/jpet.114.217372
  4. Watari, Akihiro

    1. You have access
      Development of an Anti–Claudin-3 and -4 Bispecific Monoclonal Antibody for Cancer Diagnosis and Therapy
      Xiangru Li, Manami Iida, Minoru Tada, Akihiro Watari, Yumi Kawahigashi, Yuka Kimura, Taku Yamashita, Akiko Ishii-Watabe, Tadayuki Uno, Masayoshi Fukasawa, Hiroki Kuniyasu, Kiyohito Yagi and Masuo Kondoh
      Journal of Pharmacology and Experimental Therapeutics October 2014, 351 (1) 206-213; DOI: https://doi.org/10.1124/jpet.114.216911
  5. Watkinson, Lisa D.

    1. You have access
      Relationship between Cerebral Sigma-1 Receptor Occupancy and Attenuation of Cocaine’s Motor Stimulatory Effects in Mice by PD144418
      John R. Lever, Dennis K. Miller, Emily A. Fergason-Cantrell, Caroline L. Green, Lisa D. Watkinson, Terry L. Carmack and Susan Z. Lever
      Journal of Pharmacology and Experimental Therapeutics October 2014, 351 (1) 153-163; DOI: https://doi.org/10.1124/jpet.114.216671
  6. Witkin, J. M.

    1. You have access
      Perampanel, an Antagonist of α-Amino-3-Hydroxy-5-Methyl-4-Isoxazolepropionic Acid Receptors, for the Treatment of Epilepsy: Studies in Human Epileptic Brain and Nonepileptic Brain and in Rodent Models
      R. Zwart, E. Sher, X. Ping, X. Jin, J. R. Sims, A. S. Chappell, S. D. Gleason, P. J. Hahn, K. Gardinier, D. L. Gernert, J. Hobbs, J. L. Smith, S. N. Valli and J. M. Witkin
      Journal of Pharmacology and Experimental Therapeutics October 2014, 351 (1) 124-133; DOI: https://doi.org/10.1124/jpet.114.212779
  7. Wong, Chi C.

    1. You have access
      Pegylation Improves the Pharmacokinetics and Bioavailability of Small-Molecule Drugs Hydrolyzable by Esterases: A Study of Phospho-Ibuprofen
      George Mattheolabakis, Chi C. Wong, Yu Sun, Carol A. Amella, Robert Richards, Panayiotis P. Constantinides and Basil Rigas
      Journal of Pharmacology and Experimental Therapeutics October 2014, 351 (1) 61-66; DOI: https://doi.org/10.1124/jpet.114.217208

Y

  1. Yagi, Kiyohito

    1. You have access
      Development of an Anti–Claudin-3 and -4 Bispecific Monoclonal Antibody for Cancer Diagnosis and Therapy
      Xiangru Li, Manami Iida, Minoru Tada, Akihiro Watari, Yumi Kawahigashi, Yuka Kimura, Taku Yamashita, Akiko Ishii-Watabe, Tadayuki Uno, Masayoshi Fukasawa, Hiroki Kuniyasu, Kiyohito Yagi and Masuo Kondoh
      Journal of Pharmacology and Experimental Therapeutics October 2014, 351 (1) 206-213; DOI: https://doi.org/10.1124/jpet.114.216911
  2. Yagi, Mai

    1. You have access
      HIS-388, a Novel Orally Active and Long-Acting 11β-Hydroxysteroid Dehydrogenase Type 1 Inhibitor, Ameliorates Insulin Sensitivity and Glucose Intolerance in Diet-Induced Obesity and Nongenetic Type 2 Diabetic Murine Models
      Seiji Okazaki, Takehiro Takahashi, Tomokatsu Iwamura, Junko Nakaki, Yumiko Sekiya, Mai Yagi, Hiroki Kumagai, Mikiya Sato, Satoshi Sakami, Aiko Nitta, Koji Kawai and Mie Kainoh
      Journal of Pharmacology and Experimental Therapeutics October 2014, 351 (1) 181-189; DOI: https://doi.org/10.1124/jpet.114.216556
  3. Yamashita, Taku

    1. You have access
      Development of an Anti–Claudin-3 and -4 Bispecific Monoclonal Antibody for Cancer Diagnosis and Therapy
      Xiangru Li, Manami Iida, Minoru Tada, Akihiro Watari, Yumi Kawahigashi, Yuka Kimura, Taku Yamashita, Akiko Ishii-Watabe, Tadayuki Uno, Masayoshi Fukasawa, Hiroki Kuniyasu, Kiyohito Yagi and Masuo Kondoh
      Journal of Pharmacology and Experimental Therapeutics October 2014, 351 (1) 206-213; DOI: https://doi.org/10.1124/jpet.114.216911
  4. Yamazaki, Shinji

    1. You have access
      Translational Pharmacokinetic-Pharmacodynamic Modeling for an Orally Available Novel Inhibitor of Anaplastic Lymphoma Kinase and c-Ros Oncogene 1
      Shinji Yamazaki, Justine L. Lam, Helen Y. Zou, Hui Wang, Tod Smeal and Paolo Vicini
      Journal of Pharmacology and Experimental Therapeutics October 2014, 351 (1) 67-76; DOI: https://doi.org/10.1124/jpet.114.217141
  5. Yang, Yang

    1. You have access
      Dopamine D1 Receptor Signaling: Does GαQ–Phospholipase C Actually Play a Role?
      Sang-Min Lee, Yang Yang and Richard B. Mailman
      Journal of Pharmacology and Experimental Therapeutics October 2014, 351 (1) 9-17; DOI: https://doi.org/10.1124/jpet.114.214411
  6. Yi, Xiang

    1. You have access
      Intranasal Administration as a Route for Drug Delivery to the Brain: Evidence for a Unique Pathway for Albumin
      Joseph A. Falcone, Therese S. Salameh, Xiang Yi, Benjamin J. Cordy, William G. Mortell, Alexander V. Kabanov and William A. Banks
      Journal of Pharmacology and Experimental Therapeutics October 2014, 351 (1) 54-60; DOI: https://doi.org/10.1124/jpet.114.216705

Z

  1. Zhang, Danhui

    1. You have access
      The α7 Nicotinic Receptor Agonist ABT-107 Decreases l-Dopa–Induced Dyskinesias in Parkinsonian Monkeys
      Danhui Zhang, Matthew McGregor, Michael W. Decker and Maryka Quik
      Journal of Pharmacology and Experimental Therapeutics October 2014, 351 (1) 25-32; DOI: https://doi.org/10.1124/jpet.114.216283
  2. Zhang, Youcai

    1. You have access
      Decreased Bile-Acid Synthesis in Livers of Hepatocyte-Conditional NADPH–Cytochrome P450 Reductase–Null Mice Results in Increased Bile Acids in Serum
      Xingguo Cheng, Youcai Zhang and Curtis D. Klaassen
      Journal of Pharmacology and Experimental Therapeutics October 2014, 351 (1) 105-113; DOI: https://doi.org/10.1124/jpet.114.216796
  3. Zhou, Yong

    1. You have access
      Therapeutic Targeting of Src Kinase in Myofibroblast Differentiation and Pulmonary Fibrosis
      Meng Hu, Pulin Che, Xiaosi Han, Guo-Qiang Cai, Gang Liu, Veena Antony, Tracy Luckhardt, Gene P. Siegal, Yong Zhou, Rui-ming Liu, Leena P. Desai, Philip J. O’Reilly, Victor J. Thannickal and Qiang Ding
      Journal of Pharmacology and Experimental Therapeutics October 2014, 351 (1) 87-95; DOI: https://doi.org/10.1124/jpet.114.216044
  4. Zou, Helen Y.

    1. You have access
      Translational Pharmacokinetic-Pharmacodynamic Modeling for an Orally Available Novel Inhibitor of Anaplastic Lymphoma Kinase and c-Ros Oncogene 1
      Shinji Yamazaki, Justine L. Lam, Helen Y. Zou, Hui Wang, Tod Smeal and Paolo Vicini
      Journal of Pharmacology and Experimental Therapeutics October 2014, 351 (1) 67-76; DOI: https://doi.org/10.1124/jpet.114.217141
  5. Zwart, R.

    1. You have access
      Perampanel, an Antagonist of α-Amino-3-Hydroxy-5-Methyl-4-Isoxazolepropionic Acid Receptors, for the Treatment of Epilepsy: Studies in Human Epileptic Brain and Nonepileptic Brain and in Rodent Models
      R. Zwart, E. Sher, X. Ping, X. Jin, J. R. Sims, A. S. Chappell, S. D. Gleason, P. J. Hahn, K. Gardinier, D. L. Gernert, J. Hobbs, J. L. Smith, S. N. Valli and J. M. Witkin
      Journal of Pharmacology and Experimental Therapeutics October 2014, 351 (1) 124-133; DOI: https://doi.org/10.1124/jpet.114.212779
Back to top
PreviousNext

In this issue

Journal of Pharmacology and Experimental Therapeutics: 351 (1)
Journal of Pharmacology and Experimental Therapeutics
Vol. 351, Issue 1
1 Oct 2014
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians.
  • Functional Selectivity and Classical Concepts of Quantitative Pharmacology
  • Abl Protein-Tyrosine Kinase Inhibitor STI571 Inhibits In Vitro Signal Transduction Mediated by c-Kit and Platelet-Derived Growth Factor Receptors
  • The Prediction of Human Pharmacokinetic Parameters from Preclinical and In Vitro Metabolism Data
  • A METHOD FOR DETERMINING LOSS OF PAIN SENSATION
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics